Circulating Cell-Free DNA Levels in Psychiatric Diseases: A Systematic Review and Meta-Analysis

Circulating Cell-Free DNA Levels in Psychiatric Diseases: A Systematic Review and Meta-Analysis

The cell-free DNA (cfDNA) levels are known to increase in biological fluids in various pathological conditions. However, the data on circulating cfDNA in severe psychiatric disorders, including schizophrenia, bipolar disorder (BD), and depressive disorders (DDs), is contradictory. This meta-analysis...

Full description

Bibliographic Details
Main Authors:	Mark M. Melamud, Valentina N. Buneva, Evgeny A. Ermakov
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	International Journal of Molecular Sciences
Subjects:	cfDNA cf-mtDNA DAMPs schizophrenia bipolar disorder major depressive disorder
Online Access:	https://www.mdpi.com/1422-0067/24/4/3402

Similar Items

Quantitative detection of circulating MT-ND1 as a potential biomarker for colorectal cancer
by: Yichun Xu, et al.
Published: (2021-10-01)

The Ratio of cf-mtDNA vs. cf-nDNA in the Follicular Fluid of Women Undergoing IVF Is Positively Correlated with Age
by: Georgia Tsirka, et al.
Published: (2023-07-01)

Pilot Screening of Cell-Free mtDNA in NIPT: Quality Control, Variant Calling, and Haplogroup Determination
by: Alisa Morshneva, et al.
Published: (2021-05-01)

Graft-Derived Cell-Free DNA Quantification following Liver Transplantation Using Tissue-Specific DNA Methylation and Donor-Specific Genotyping Techniques: An Orthogonal Comparison Study
by: Daniel R. A. Cox, et al.
Published: (2023-06-01)

Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
by: Morten Lapin, et al.
Published: (2018-11-01)

Circulating cell-free DNA as a biomarker for diagnosis of Schistosomiasis japonica
by: Yu Zhang, et al.
Published: (2024-03-01)

Circulating Cell-Free DNA as a Prognostic Biomarker in Resectable Ampullary Cancer
by: Bor-Uei Shyr, et al.
Published: (2021-05-01)

Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood
by: Stine H. Kresse, et al.
Published: (2023-09-01)

Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review
by: Adrian Martuszewski, et al.
Published: (2021-01-01)

Molecular Mechanisms of mtDNA-Mediated Inflammation
by: Anna De Gaetano, et al.
Published: (2021-10-01)

Comparing cell‐free circulating tumor DNA mutational profiles of disease‐free and nonresponders patients with oropharyngeal squamous cell carcinoma
by: Alok R. Khandelwal, et al.
Published: (2020-10-01)

Ultra Deep Sequencing of Circulating Cell-Free DNA as a Potential Tool for Hepatocellular Carcinoma Management
by: Mónica Higuera, et al.
Published: (2022-08-01)

Targeted fetal cell‐free DNA screening for aneuploidies in 4,594 pregnancies: Single center study
by: Altug Koc, et al.
Published: (2019-07-01)

Mitochondrial DNA and Exercise: Implications for Health and Injuries in Sports
by: Giada Zanini, et al.
Published: (2021-09-01)

Fluorometric Quantification of Total Cell-Free DNA as a Prognostic Biomarker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade
by: Javier Oliver, et al.
Published: (2023-06-01)

Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation
by: Jonathan Dao, et al.
Published: (2023-08-01)

The cfDNA in early cancer detection
by: Hussein Adil Abid, et al.
Published: (2024-01-01)

A new primer construction technique that effectively increases amplification of rare mutant templates in samples
by: Jr-Kai Huang, et al.
Published: (2019-08-01)

Application of cell-free DNA sequencing in characterization of bloodborne microbes and the study of microbe-disease interactions
by: Kuo-Ping Chiu, et al.
Published: (2019-08-01)

Deep cfDNA fragment end profiling enables cancer detection
by: Yulia V. Zhitnyuk, et al.
Published: (2022-01-01)

Biguanide chitosan microneedles with cell-free DNA scavenging ability for psoriasis therapy
by: Zihao Liu, et al.
Published: (2024-03-01)

Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas
by: Ramón Diez-Feijóo, et al.
Published: (2024-01-01)

Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms
by: Stefan Grabuschnig, et al.
Published: (2020-10-01)

Rapid and Efficient Extraction of Cell-Free DNA Using Homobifunctional Crosslinkers
by: HyeonAh Seong, et al.
Published: (2022-08-01)

Detecting cancer from cell-free DNA sequencing fragmentation patterns
by: Chen, L
Published: (2023)

Reduced Serum Circulation of Cell-Free DNA Following Chemotherapy in Breast Cancer Patients
by: Evelyn Adusei, et al.
Published: (2021-05-01)

Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resistant Prostate Cancer
by: Bram De Laere, et al.
Published: (2021-03-01)

BL-MOL-AR Project, Preliminary Results about Liquid Biopsy: Molecular Approach Experience and Research Activity in Oncological Settings
by: Pancrazzi Pancrazzi, et al.
Published: (2023-09-01)

Cell-Free DNA in Plasma and Serum Indicates Disease Severity and Prognosis in Blunt Trauma Patients
by: Inga Trulson, et al.
Published: (2023-03-01)

Bisulfite Amplicon Sequencing Can Detect Glia and Neuron Cell-Free DNA in Blood Plasma
by: Zac Chatterton, et al.
Published: (2021-07-01)

IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients
by: Stefania Crucitta, et al.
Published: (2024-01-01)

Cell-Free DNA Variant Sequencing Using Plasma and AR-V7 Testing of Circulating Tumor Cells in Prostate Cancer Patients
by: Verena Lieb, et al.
Published: (2021-11-01)

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA
by: Cleo Keppens, et al.
Published: (2018-08-01)

Clinical significance of circulating tumor cells and cell‐free DNA in pediatric rhabdomyosarcoma
by: Lucia Tombolan, et al.
Published: (2022-05-01)

Cell-Free DNA Fragmentation Patterns in a Cancer Cell Line
by: Vida Ungerer, et al.
Published: (2022-08-01)

Clinical Validity of Circulating Tumor DNA as Prognostic and Predictive Marker for Personalized Colorectal Cancer Patient Management
by: Ariane Hallermayr, et al.
Published: (2022-02-01)

5-Hydroxymethylcytosines in circulating cell-free DNA reveal a diagnostic biomarker for glioma
by: Chunyu Zhang, et al.
Published: (2022-10-01)

The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review
by: Ian A. Cree, et al.
Published: (2017-10-01)

A Fully Integrated Microfluidic Device with Immobilized Dyes for Simultaneous Detection of Cell-Free DNA and Histones from Plasma Using Dehydrated Agarose Gates
by: Shadi Shahriari, et al.
Published: (2024-03-01)

Can Liquid Biopsy Based on ctDNA/cfDNA Replace Tissue Biopsy for the Precision Treatment of EGFR-Mutated NSCLC?
by: Yi-Ze Li, et al.
Published: (2023-02-01)